Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Osanai, T.
Right arrow Articles by Sugihara, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Osanai, T.
Right arrow Articles by Sugihara, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 31:500-505 (2001)
© 2001 Foundation for Promotion of Cancer Research

Expression of Pyrimidine Nucleoside Phosphorylase (PyNPase) in Colorectal Cancer

Takayuki Osanai, Wataru Ichikawa, Yoko Takagi, Hiroyuki Uetake, Zenro Nihei and Kenichi Sugihara+

Digestive Surgery, Tokyo Medical and Dental University, Graduate School, Tokyo, Japan

Background: We investigated the expression of PyNPase both in cancer cells and in stroma cells to clarify the correlation between PyNPase expression and the prognosis of patients with colorectal cancer.

Methods: Using immunohistochemical staining with an anti-PyNPase antibody, the PyNPase expression in tissues from 114 patients with stage II or III colorectal cancer was examined. From the correlation between PyNPase expression and the clinicopathological findings, the prognosis for survival was analyzed.

Results: The expression of PyNPase was classified as negative or positive on the basis of staining. No relationship between PyNPase expression and any of the clinicopathological findings was identified. However, a relationship was observed regarding positive staining between cancer cells and stroma cells. The prognosis of patients with positive staining in both cancer cells and stroma was worse than that of other patients. In multivariate analyses, expression in cancer cells was the strongest predictor of prognosis.

Conclusions: PyNPase expression appears to be a relevant factor for predicting the prognosis of colorectal cancer.

+ For reprints and all correspondence: Takayuki Osanai, Digestive Surgery, Tokyo Medical and Dental University, Graduate School, 1–5–45, Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. E-mail: t-osanai.srg2@tmd.ac.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.